loading
Schlusskurs vom Vortag:
$2.84
Offen:
$2.84
24-Stunden-Volumen:
802.57K
Relative Volume:
0.12
Marktkapitalisierung:
$583.70M
Einnahmen:
$116.33M
Nettoeinkommen (Verlust:
$-209.25M
KGV:
-1.3656
EPS:
-2.12
Netto-Cashflow:
$-135.49M
1W Leistung:
+6.65%
1M Leistung:
+9.06%
6M Leistung:
+189.18%
1J Leistung:
+41.67%
1-Tages-Spanne:
Value
$2.80
$2.93
1-Wochen-Bereich:
Value
$2.73
$3.11
52-Wochen-Spanne:
Value
$0.6925
$3.94

Esperion Therapeutics Inc Stock (ESPR) Company Profile

Name
Firmenname
Esperion Therapeutics Inc
Name
Telefon
734-887-3903
Name
Adresse
3891 RANCHERO DRIVE, SUITE 150, ANN ARBOR, MI
Name
Mitarbeiter
304
Name
Twitter
@esperioninc
Name
Nächster Verdiensttermin
2025-03-04
Name
Neueste SEC-Einreichungen
Name
ESPR's Discussions on Twitter

Vergleichen Sie ESPR mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Specialty & Generic icon
ESPR
Esperion Therapeutics Inc
2.895 657.81M 116.33M -209.25M -135.49M -2.12
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
143.22 63.86B 9.39B 2.62B 2.22B 5.8121
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.45 41.80B 29.96B 957.25M 4.77B 0.2956
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.195 40.88B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
20.12 22.98B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
449.15 19.53B 3.08B 1.24B 1.07B 25.61

Esperion Therapeutics Inc Stock (ESPR) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-12-18 Eingeleitet Goldman Neutral
2024-12-17 Eingeleitet Cantor Fitzgerald Overweight
2024-06-20 Herabstufung BofA Securities Neutral → Underperform
2024-01-03 Herabstufung BofA Securities Buy → Neutral
2023-11-20 Fortgesetzt JP Morgan Neutral
2023-08-01 Hochstufung Northland Capital Under Perform → Market Perform
2023-06-15 Hochstufung BofA Securities Underperform → Buy
2023-03-16 Herabstufung BofA Securities Neutral → Underperform
2023-03-16 Herabstufung Northland Capital Market Perform → Under Perform
2023-03-07 Hochstufung Credit Suisse Underperform → Neutral
2023-02-27 Fortgesetzt BofA Securities Neutral
2023-02-24 Hochstufung Jefferies Hold → Buy
2023-02-03 Hochstufung Morgan Stanley Underweight → Equal-Weight
2022-08-03 Herabstufung Credit Suisse Neutral → Underperform
2022-05-05 Hochstufung JP Morgan Underweight → Neutral
2022-03-10 Eingeleitet H.C. Wainwright Buy
2021-10-19 Herabstufung Credit Suisse Outperform → Neutral
2021-10-14 Herabstufung Morgan Stanley Equal-Weight → Underweight
2021-05-05 Herabstufung Stifel Buy → Hold
2021-04-26 Fortgesetzt Credit Suisse Outperform
2021-03-11 Eingeleitet Morgan Stanley Equal-Weight
2021-02-12 Herabstufung Jefferies Buy → Hold
2021-02-09 Herabstufung Goldman Neutral → Sell
2021-01-15 Herabstufung BofA Securities Buy → Neutral
2020-11-10 Hochstufung Credit Suisse Neutral → Outperform
2020-09-29 Fortgesetzt JP Morgan Underweight
2020-08-11 Herabstufung Credit Suisse Outperform → Neutral
2020-04-01 Fortgesetzt BofA/Merrill Buy
2020-03-17 Hochstufung Citigroup Neutral → Buy
2020-02-24 Herabstufung Northland Capital Outperform → Market Perform
2020-02-14 Herabstufung Citigroup Buy → Neutral
2019-09-16 Hochstufung Goldman Sell → Neutral
2019-05-29 Herabstufung Goldman Neutral → Sell
2019-05-06 Hochstufung BofA/Merrill Underperform → Neutral
2019-04-26 Hochstufung Goldman Sell → Neutral
2019-03-13 Hochstufung JP Morgan Underweight → Neutral
2019-01-07 Bestätigt Needham Strong Buy
2018-12-13 Eingeleitet Goldman Sell
2018-10-29 Hochstufung Northland Capital Market Perform → Outperform
2018-10-16 Eingeleitet BTIG Research Buy
2018-08-17 Hochstufung Citigroup Neutral → Buy
2018-07-11 Herabstufung Northland Capital Outperform → Market Perform
2018-05-03 Herabstufung JP Morgan Neutral → Underweight
2018-05-02 Herabstufung BofA/Merrill Buy → Underperform
Alle ansehen

Esperion Therapeutics Inc Aktie (ESPR) Neueste Nachrichten

pulisher
06:52 AM

Why analysts remain bullish on Esperion Therapeutics Inc. stockWeekly Loss Report & Real-Time Volume Analysis - newser.com

06:52 AM
pulisher
06:49 AM

Can volume confirm reversal in Esperion Therapeutics Inc.July 2025 Intraday Action & Verified Swing Trading Watchlists - newser.com

06:49 AM
pulisher
06:25 AM

Is Esperion Therapeutics Inc. stock reversal real or fake2025 Market WrapUp & Accurate Buy Signal Alerts - newser.com

06:25 AM
pulisher
05:59 AM

Multi asset correlation models including Esperion Therapeutics Inc.July 2025 Drop Watch & Growth Focused Stock Reports - newser.com

05:59 AM
pulisher
05:41 AM

Esperion Therapeutics (ESPR) to Release Quarterly Earnings on Thursday - MarketBeat

05:41 AM
pulisher
05:17 AM

Can Esperion Therapeutics Inc. stock deliver surprise earnings beat2025 Technical Patterns & Safe Capital Preservation Plans - newser.com

05:17 AM
pulisher
04:37 AM

Will Esperion Therapeutics Inc. (0ET) stock benefit from mergersEarnings Growth Summary & Low Drawdown Investment Ideas - newser.com

04:37 AM
pulisher
04:30 AM

Why analysts raise outlook for Esperion Therapeutics Inc. (0ET) stockMarket Activity Report & Free Technical Confirmation Trade Alerts - newser.com

04:30 AM
pulisher
02:13 AM

Relative strength of Esperion Therapeutics Inc. in sector analysisEarnings Growth Report & Risk Controlled Daily Plans - newser.com

02:13 AM
pulisher
01:34 AM

Smart tools for monitoring Esperion Therapeutics Inc.’s price action2025 Market Trends & Technical Buy Zone Confirmation - newser.com

01:34 AM
pulisher
01:24 AM

Will earnings trigger a reversal in Esperion Therapeutics Inc.2025 Big Picture & Technical Entry and Exit Alerts - newser.com

01:24 AM
pulisher
Oct 30, 2025

Using AI based signals to follow Esperion Therapeutics Inc.Portfolio Growth Summary & Fast Gaining Stock Strategy Reports - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

How high can Esperion Therapeutics Inc. stock go2025 Earnings Surprises & Risk Adjusted Buy/Sell Alerts - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Why Esperion Therapeutics Inc. stock is favored by top institutionsGDP Growth & Verified High Yield Trade Plans - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Published on: 2025-10-30 01:22:55 - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Identifying reversal signals in Esperion Therapeutics Inc.Quarterly Trade Summary & Low Drawdown Trading Strategies - newser.com

Oct 30, 2025
pulisher
Oct 29, 2025

Applying Elliott Wave Theory to Esperion Therapeutics Inc.Quarterly Market Review & Community Consensus Trade Signals - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Why Esperion Therapeutics Inc. is moving todayEarnings Miss & Weekly High Conviction Trade Ideas - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Esperion Therapeutics (NASDAQ:ESPR) Trading 7.1% HigherTime to Buy? - MarketBeat

Oct 29, 2025
pulisher
Oct 29, 2025

How to integrate Esperion Therapeutics Inc. into portfolio analysis toolsWeekly Volume Report & Step-by-Step Swing Trade Plans - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Published on: 2025-10-28 23:56:41 - newser.com

Oct 29, 2025
pulisher
Oct 28, 2025

Esperion to Host Virtual Investor Key Opinion Leader Event Highlighting Significant Unmet Need in Statin Intolerance on Tuesday, November 11, 2025, at 2:00 p.m. ET. - The Manila Times

Oct 28, 2025
pulisher
Oct 28, 2025

How Esperion Therapeutics Inc. stock benefits from global expansion2025 Technical Patterns & Fast Entry High Yield Tips - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Esperion (NASDAQ: ESPR) sets Nov. 11, 2 p.m. ET KOL webinar on statin intolerance - Stock Titan

Oct 28, 2025
pulisher
Oct 28, 2025

Will Esperion Therapeutics Inc. stock return to pre crisis levelsWeekly Gains Summary & High Conviction Buy Zone Picks - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Can Esperion Therapeutics Inc. stock reach $100 price targetPortfolio Risk Summary & Technical Pattern Alert System - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Will Esperion Therapeutics Inc. stock gain from lower inflation2025 Performance Recap & Risk Managed Trade Strategies - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

How to use Fibonacci retracement on Esperion Therapeutics Inc.Quarterly Trade Summary & Real-Time Sentiment Analysis - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Should you wait for a breakout in Esperion Therapeutics Inc.Earnings Recap Summary & AI Driven Stock Movement Reports - newser.com

Oct 28, 2025

Finanzdaten der Esperion Therapeutics Inc-Aktie (ESPR)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$46.22
price up icon 4.84%
drug_manufacturers_specialty_generic RDY
$13.34
price down icon 0.86%
$22.71
price up icon 0.63%
$10.39
price up icon 0.39%
$139.30
price up icon 0.88%
$446.89
price down icon 1.46%
Kapitalisierung:     |  Volumen (24h):